Retained viscoelastic can cause reticular interface haze

Article

Retained viscoelastic at the graft-host interface during DSEK may cause a reticular interface haze that can compromise visual clarity.

Retained viscoelastic at the graft-host interface during DSEK may cause a reticular interface haze that can compromise visual clarity, claims a paper in Retina.

A group led by Dr A. Anshu, Cornea Research Foundation of America, Indianapolis, Indiana, USA, studied five patients who underwent uncomplicated combined DSAEK/phacoemulsification with IOL implantation at a tertiary referral centre over a period of three months.

Each eye had the Descemet membrane stripped and the anterior chamber filled cohesive viscoelastic. As a result, patients developed visually significant haze in the graft-host interface. There was also a small separation between the donor and the recipient cornea in three of the fives cases.

In all patients there was no communication between the area of detachment and the anterior chamber. Patients either went under observation or had surgery to irrigate the viscoelastic from the interface.

Three patients were observed with eventual clearing of the haze and attainment of best-corrected visual acuity of 20/40 or better. The remaining two patients had more extensive haze and visible space on the slit lamp examination and underwent irrigation and aspiration of the graft-host interface. At the last follow-up all grafts were clear.

The abstract can be found here.

Newsletter

Join ophthalmologists across Europe—sign up for exclusive updates and innovations in surgical techniques and clinical care.

Recent Videos
A photo of Seville, Spain, with the Congress on Controversies in Ophthalmology logo superimposed on it. Image credit: ©francovolpato – stock.adobe.com; logo courtesy COPHy
Anat Loewenstein, MD, Professor and Director, Department of Ophthalmology, Tel Aviv Medical Center, discusses the Congress on Controversies in Ophthalmology (COPHy)
Anat Loewenstein, MD, speaks about the 22nd Annual Angiogenesis, Exudation, and Degeneration Meeting in February 2025 and shares her global forecast for AI-driven home OCT
Sarah M. Thomasy, DVM, PhD, DACVO, a veterinary ophthalmologist at UC Davis, talks about how her research at the Glaucoma 360 symposium
I. Paul Singh, MD, an anterior segment and glaucoma specialist, discusses the Glaucoma 360 conference, where he participated in a panel discussion on the use of artificial intelligence (AI) in glaucoma care.
Charles Wykoff, MD, PhD, discusses his Floretina ICOOR presentation topic, retinal non-perfusion in diabetic retinopathy, with David Hutton, editor of Ophthalmology Times
Elizabeth Cohen, MD, discusses the Zoster Eye Disease study at the 2024 AAO meeting
Victoria L Tseng, MD, PhD, professor of ophthalmology and glaucoma specialist, UCLA
© 2025 MJH Life Sciences

All rights reserved.